Efineptakin alfa (NT-I7) improves overall survival and induces tertiary lymphoid structures in murine lung tumors
Trang Dinh, Judong Lee, Sidra Islam, Namita Nanda, Dijana Bjelivuk, Dathan Andrews, Jiasen Zhang, Nikita Lavanya Mani, Jin Zhou, Alexandra A. Wolfarth, Donghoon Choi, Rafi Ahmed, Joseph J. Skitzki, Deyu Fang, Weihong Guo, , Rebecca C. Obeng
This study shows efineptakin alfa (NT-I7) improves survival and induces tertiary lymphoid structures in murine lung tumors, potentially enhancing immunotherapy efficacy.
bioRxiv · Sep 15, 2025 · PreprintImmunology